» Articles » PMID: 35448154

Engaging Patients in Smoking Cessation Treatment Within the Lung Cancer Screening Setting: Lessons Learned from an NCI SCALE Trial

Overview
Journal Curr Oncol
Publisher MDPI
Specialty Oncology
Date 2022 Apr 21
PMID 35448154
Authors
Affiliations
Soon will be listed here.
Abstract

Offering smoking cessation treatment at lung cancer screening (LCS) will maximize mortality reduction associated with screening, but predictors of treatment engagement are not well understood. We examined participant characteristics of engagement in an NCI SCALE cessation trial. Eligible LCS patients (N = 818) were randomized to the Intensive arm (8 phone counseling sessions +8 weeks of nicotine replacement therapy (NRT)) vs. Minimal arm (3 sessions + 2 weeks of NRT). Engagement was measured by number of sessions completed (none, some, or all) and NRT mailed (none vs. any) in each arm. In the Intensive arm, those with ≥some college (OR = 2.1, 95% CI = 1.1, 4.0) and undergoing an annual scan (OR = 2.1, 95% CI = 1.1, 4.2) engaged in some counseling vs. none. Individuals with higher nicotine dependence were more likely (OR = 2.8, 95% CI = 1.3, 6.2) to request NRT. In the Minimal arm, those with higher education (OR = 2.1, 95% CI = 1.1, 3.9) and undergoing an annual scan (OR = 2.0, 95% CI = 1.04, 3.8) completed some sessions vs. none. Requesting NRT was associated with more pack-years (OR = 1.9, 95% CI = 1.1, 3.5). Regardless of treatment intensity, additional strategies are needed to engage those with lower education, less intensive smoking histories, and undergoing a first scan. These efforts will be important given the broader 2021 LCS guidelines.

Citing Articles

Association of individual and neighborhood socioeconomic status with outcomes of a smoking cessation intervention provided in the lung cancer screening setting.

Avila J, Flores E, Su Y, Haas J, Park E, Rigotti N Prev Med. 2024; 191:108207.

PMID: 39694102 PMC: 11776097. DOI: 10.1016/j.ypmed.2024.108207.

References
1.
Marshall H, Courtney D, Passmore L, McCaul E, Yang I, Bowman R . Brief Tailored Smoking Cessation Counseling in a Lung Cancer Screening Population is Feasible: A Pilot Randomized Controlled Trial. Nicotine Tob Res. 2016; 18(7):1665-9. DOI: 10.1093/ntr/ntw010. View

2.
Taylor K, Cox L, Zincke N, Mehta L, McGuire C, Gelmann E . Lung cancer screening as a teachable moment for smoking cessation. Lung Cancer. 2007; 56(1):125-34. DOI: 10.1016/j.lungcan.2006.11.015. View

3.
Park E, Chiles C, Cinciripini P, Foley K, Fucito L, Haas J . Impact of the COVID-19 pandemic on telehealth research in cancer prevention and care: A call to sustain telehealth advances. Cancer. 2020; 127(3):334-338. PMC: 7675475. DOI: 10.1002/cncr.33227. View

4.
Hestbech M, Siersma V, Dirksen A, Pedersen J, Brodersen J . Participation bias in a randomised trial of screening for lung cancer. Lung Cancer. 2011; 73(3):325-31. DOI: 10.1016/j.lungcan.2010.12.018. View

5.
Neil J, Marotta C, Gonzalez I, Chang Y, Levy D, Wint A . Integrating tobacco treatment into lung cancer screening practices: Study protocol for the Screen ASSIST randomized clinical trial. Contemp Clin Trials. 2021; 111:106586. PMC: 8874354. DOI: 10.1016/j.cct.2021.106586. View